Personalized medicine in bipolar disorder: how can we overcome the barriers to clinical translation?

Author： Squassina Alessio   Pisanu Claudia  

Publisher： Future Medicine

ISSN： 1741-0541

Source： Personalized Medicine, Vol.10, Iss.8, 2013-11, pp. : 765-768

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Personalized medicine: how much can we afford? A bioethics perspective

By Lunshof Jeantine  

Personalized Medicine, Vol. 2, Iss. 1, 2005-02 ,pp. : 43-47

Future Medicine

Access to resources Recommend Favorite

How can evolutionary medicine inform future personalized medicine?

By Henneberg Maciej   Saniotis Arthur  

Personalized Medicine, Vol. 9, Iss. 2, 2012-03 ,pp. : 171-173

Future Medicine

Access to resources Recommend Favorite

Does personalized medicine exist and can you test it in a clinical trial?

By  

INTERNATIONAL JOURNAL OF STROKE, Vol. 10, Iss. 7, 2015-10 ,pp. : 994-999

John Wiley & Sons Inc

Access to resources Recommend Favorite

How can we remove barriers to HIV testing outside of a GUM setting?

By Barber Tristan J   Menon-Johansson Anatole   Barton Simon  

British Journal of General Practice, Vol. 58, Iss. 550, 2008-05 ,pp. : 365-365

Royal College of General Practitioners

Access to resources Recommend Favorite

Can (and will) governments afford personalized medicine?

By Taylor David   Al-Saeed Eman  

Personalized Medicine, Vol. 7, Iss. 5, 2010-09 ,pp. : 587-595

Future Medicine

Access to resources Recommend Favorite